Immunotherapy combined with chemotherapy: a promising therapeutic approach in the management of colonic squamous cell carcinoma—a case report
Colorectal squamous cell carcinoma (CSCC) is an exceedingly rare malignancy, accounting for approximately 0.41% of all colorectal cancers. This case report describes a 52-year-old male with a history of chronic bronchitis, varicose vein of the lower limb, diabetes, and Hepatitis B cirrhosis, who pre...
Saved in:
| Main Authors: | Bingbing Ren, Haitao Yang, Yingying Mao |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-05-01
|
| Series: | Frontiers in Oncology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2025.1548008/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Negative response to immunotherapy in dMMR or MSI-H gastric cancer with APC and PTEN mutations: a case report
by: Jiang Liu, et al.
Published: (2024-11-01) -
Real world effectiveness of chemotherapy plus bevacizumab with immunotherapy in colorectal cancer
by: Zhao Gao, et al.
Published: (2025-08-01) -
Immunotherapy-induced microsatellite instability status shift in recurrent perihilar cholangiocarcinoma: A case report
by: Hailing Yu, et al.
Published: (2025-12-01) -
Patient-derived colorectal microtumors predict response to anti-PD-1 therapy
by: Duy T. Nguyen, et al.
Published: (2025-08-01) -
PD-L1 Expression in Colorectal Cancer and Its Relation to Microsatellite Instability and Cytotoxic Tumor-Infiltrating Lymphocytes
by: Suzan Talaat, et al.
Published: (2024-12-01)